Back to Journals » OncoTargets and Therapy » Volume 14

Bronchiolar Adenoma Transforming to Invasive Mucinous Adenocarcinoma: A Case Report

Authors Han X, Hao J, Ding S, Wang EH, Wang L

Received 31 December 2020

Accepted for publication 16 March 2021

Published 30 March 2021 Volume 2021:14 Pages 2241—2246

DOI https://doi.org/10.2147/OTT.S299864

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Arseniy Yuzhalin


Xu Han,1,* Jialin Hao,2,* Suling Ding,3 En-Hua Wang,1 Liang Wang1

1Department of Pathology, First Affiliated Hospital and College of Basic Medical Sciences, China Medical University, Shenyang, People’s Republic of China; 2Key Laboratory of Medical Cell Biology, Ministry of Education, China Medical University, Shenyang, People’s Republic of China; 3Department of Pathology, Jinzhou Central Hospital, Jinzhou, People’s Republic of China

*These authors contributed equally to this work

Correspondence: Liang Wang
Department of Pathology, First Affiliated Hospital and College and Basic Medical Sciences, China Medical University, Shenyang, People’s Republic of China
Tel/Fax +86 24 23261638
Email [email protected]

Abstract: Bronchiolar adenoma (BA) is recognized as a neoplasm with benign clinical course. Histologically, BA is characterized by nodular proliferation of the bilayered bronchiolar-type epithelium, including multipartite epithelial cells and a continuous layer of basal cells. Recent reports have revealed the frequent presence of driver gene mutations in BA, suggesting its neoplastic nature. However, it is still debatable whether BA has malignant potential. Herein, we report the first case of BA harboring the same KRAS mutation with the adjacent invasive mucinous adenocarcinoma (IMA). Additionally, the loss of continuity of the basal cell layer in the junctional zone between BA and IMA indicated a malignant transformation from BA to IMA in this particular case.

Keywords: bronchiolar adenoma, invasive mucinous adenocarcinoma, KRAS, transformation

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]